Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

  • There is currently no data for AGL

Geomerics secures joint development agreement

15 Mar 2010 09:59

RNS Number : 5676I
Angle PLC
15 March 2010
 



 

 

For immediate release

15 March 2010

 

ANGLE plc ("the Company")

Geomerics secures joint development agreement with CCP and Epic Games

 

ANGLE plc ("ANGLE"), the international venture management company focusing on the commercialisation of technology and the development of technology-based industry, is delighted to announce that its 47% portfolio company Geomerics has entered into a joint development agreement with CCP, creator of Eve Online, to integrate Geomerics' Enlighten real-time radiosity lighting product with Epic Games' Unreal Engine 3 for use in the development of DUST 514™.

 

DUST 514™ is the genre-defining, console MMO First-Person Shooter set within the same universe as EVE Online, the award-winning science-fiction MMO for the PC platform.

 

Currently in development at CCP's Shanghai studio, DUST 514 is the first scheduled console game to combine the use of Enlighten with Unreal Engine 3 to produce fully dynamic lighting for console platforms.

 

Thanks to their joint work with CCP, Geomerics' cutting-edge middleware lighting technology is now fully integrated with DUST 514. The only genuine real time radiosity product for gaming, Enlighten enables artists to enhance mood and atmosphere through lighting design at minimal cost.

 

"Having already produced stunning real-time radiosity results with Geomerics' Enlighten technology on the PC platform, we entered into a partnership with them to integrate their technology with Unreal Engine 3. The results knocked my socks off," said Hilmar Petursson, CEO of CCP. "Additionally, we now have rapid iteration on the lighting which is crucial to achieve the high bar we have set for Dust 514."

 

"Our advanced lighting technology will help players immerse themselves in the incredible universe CCP is creating," said Gary Lewis, CEO Geomerics. "We look forward to seeing how CCP will take advantage of the integration between Unreal Engine 3 and Enlighten in this new category of videogame."

 

 

For further information:

 

ANGLE plc

01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

 

Collins Stewart Europe Limited

Stewart Wallace

 

0207 523 8350

Scott Harris

Stephen Scott, James O'Shaughnessy, Harry Dee

 

0207 653 0030

 

 

Notes to Editors

 

ANGLE plc 

 

Founded in 1994, ANGLE is an international venture management company focusing on the commercialisation of technology and the development of technology-based industry. ANGLE creates, develops and advises technology businesses on its own behalf and for its clients.

 

ANGLE's specialist Management services business provides support on a fee-for-service basis to major clients around the world involved in incubation, IP commercialisation, SME innovation and growth and the operation of science & technology parks.

 

ANGLE also owns a portfolio of companies with high growth potential in the medical and technology sectors in both the UK and the US. These have been developed whilst subsidiaries of ANGLE using its proprietary Progeny® process. ANGLE seeks to retain a substantial shareholding in these companies with a view to ongoing returns from dividend, milestone, royalty and capital returns.

 

ANGLE's venture management and technology commercialisation skills are of increasing relevance as global economies focus on regeneration, innovation and value added components to their industries. ANGLE's technology skills in IT and software, medical and life sciences, clean tech and renewable energies are directly relevant to major growth markets of the future and are marketed as specialised Management services.

 

ANGLE is quoted on AIM (AGL.L); further information can be found on www.ANGLEplc.com 

 

CCP

 

CCP is a privately held company that specializes in the creation, development and distribution of massively multiplayer online games (MMOG). Founded in 1997, CCP is recognized internationally as a pioneer in the single-server persistent universe concept of the MMOG genre. CCP is headquartered in Reykjavík, Iceland.

 

Unreal Engine 3

 

The award-winning Unreal Engine is known for cutting-edge graphics and its best-of-breed toolset. Unreal Engine 3 maintains those features in addition to multi-core processor support, Xbox 360® and PLAYSTATION®3 optimizations, massive world support, and a highly mature tool pipeline. Unreal Engine 3's consistently evolving toolset is designed to accelerate developers' productivity for PC and console games, visualization applications, training simulations, and linear animated content. Additional information on Unreal Engine can be obtained through the Unreal Technology Web site at www.unrealtechnology.com.

 

Epic Games

 

Epic Games, Inc., based in Cary, NC and established in 1991, develops cutting-edge games and cross-platform game engine technology. The company has created multiple million-selling, award-winning titles in its "Unreal" series, including "Unreal Tournament 3" for PC, PLAYSTATION®3 and Xbox 360®. Epic's "Gears of War" won over 30 Game of the Year awards, and the sales of "Gears of War" and "Gears of War 2" have eclipsed 11 million units. Epic's Unreal Engine 3 is the three-time consecutive winner of Game Developer magazine's Best Engine Front Line Award, was the 2008 Hall of Fame inductee and won Best Engine again in 2009. Unreal Engine 3 has also been recognized as the number one game engine by Develop magazine. Additional information about Epic can be obtained through the Epic Games Web site at www.epicgames.com.

 

Epic, Epic Games, Gears of War, Gears of War 2, Unreal, Unreal Engine and Unreal Tournament are trademarks or registered trademarks of Epic Games, Inc. in the United States of America and elsewhere. All other trademarks are the property of their respective owners.

 

Geomerics

 

Geomerics is an innovation-led company specialising in graphics software for the games industry. It is built on a combination of advanced in-house IP, a world-class research team, and strong management experience. The company's first product is Enlighten. Enlighten radically transforms the way that lighting is handled in computer games. Instead of pre-baking the effects of global illumination into the scene they can now be computed at run time, allowing for fully dynamic lighting. This dramatically enhances realism as well as opening up a new world of creative possibilities for designers and artists. Further information can be found on www.geomerics.com, or see us on the Intel and nVidia booths at GDC 2010.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLIFEAVDIELII
Date   Source Headline
29th Oct 20257:00 amRNS-RCHANGE OF NAME
16th Oct 20257:00 amRNSAppointments: Interim CEO and senior board advisor
8th Oct 20257:00 amRNSStrategy Update
29th Sep 20257:00 amRNS-RPresentation of Data on Glioblastoma
12th Sep 20257:00 amRNSBoard Changes
9th Sep 20257:01 amRNSInterim Results
9th Sep 20257:00 amRNSChange of Adviser
5th Sep 20252:58 pmRNSNotice of Results
20th Aug 20257:00 amRNSANGLE announces collaboration with Myriad Genetics
8th Jul 20257:00 amRNS-RPARSORTIX ENABLES STUDY OF CANCER PROGRESSION
30th Jun 20255:50 pmRNSResult of 2025 Annual General Meeting
17th Jun 20257:00 amRNS-REACR 2025: Innovation in AR expression profiling
17th Jun 20257:00 amRNS-REACR 2025: Data demonstrating DNA dual analysis
10th Jun 20257:00 amRNS-RNovel discoveries into the biology of cancer
9th Jun 20257:00 amRNSPOSTING OF ANNUAL REPORT AND NOTICE OF AGM
6th Jun 20257:00 amRNSBoard Changes
28th May 20257:00 amRNSPreliminary Results
23rd May 20257:00 amRNSNotice of Results
28th Apr 20257:00 amRNS-RRESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
21st Mar 20257:00 amRNSIssue of LTIP Options and Share Options
21st Mar 20257:00 amRNSResults of Eisai Phase 2 pilot study
6th Feb 20257:00 amRNS-RNovel findings using Parsortix
29th Jan 20257:00 amRNSAnalysis of CTC-DNA and ctDNA using Illumina assay
24th Jan 202510:05 amRNS-RParsortix used in research paper from ETH Zurich
23rd Jan 20257:00 amRNSTrading Update
26th Sep 20247:00 amRNSHalf-year Report
23rd Sep 20247:00 amRNSExclusive agreement for DNA NGS panel
17th Sep 20247:00 amRNSNotice of Interim Results and Webcast
18th Jul 202410:08 amRNSStandard form for notification of major holdings
12th Jul 20243:38 pmRNSStandard form for notification of major holdings
11th Jul 20243:07 pmRNSResult of 2024 Annual General Meeting
21st Jun 20247:00 amRNSResult of open offer
18th Jun 20242:41 pmRNSPosting of 2023 Annual Report & Notice of the AGM
11th Jun 20247:00 amRNSParsortix and assays being showcased at EACR 2024
6th Jun 20244:37 pmRNSPublication of Circular
5th Jun 20244:04 pmRNSResults of placing and subscription
5th Jun 20247:00 amRNSProposed Placing, Subscription and Open Offer
5th Jun 20247:00 amRNSPreliminary Results
16th May 20247:00 amRNSStudy of ovarian cancer CTCs using Parsortix
3rd May 20247:00 amRNSNew commercial agreement with large pharma
24th Apr 20247:00 amRNSNew commercial agreement with AstraZeneca
22nd Apr 20247:00 amRNSUS and EU patents for innovative CellKeep™ slide
8th Apr 20247:00 amRNSParsortix HER2 assay showcased at AACR 2024
22nd Mar 20247:00 amRNSParsortix at European breast cancer conference
22nd Jan 20247:00 amRNSPotential utility in precision oncology
10th Jan 202412:57 pmRNSStandard form for notification of major holdings
4th Jan 20247:00 amRNSBreakthrough clinical results
2nd Jan 20247:00 amRNSContract announcement with Eisai Inc.
11th Dec 20237:00 amRNSBroker Announcement
11th Dec 20237:00 amRNSParsortix unlocks opportunities for drug discovery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.